Search
Search Results
##search.searchResults.foundPlural##
-
COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.
2522PDF: 945HTML: 306 -
MEDICAL TREATMENT OF HEPATOCELLULAR CARCINOMA
737PDF: 470HTML: 6272 -
IMPLEMENTATION OF MICROELIMINATION STRATEGY IN ERADICATION OF CHRONIC HEPATITIS C INFECTION IN PATIENTS WITH HEMOPHILIA IN THE NORTHERN REGION OF SERBIA Microelimination Strategy of Chronic Hepatitis C Infection in patients with Hemophilia
892PDF: 368HTML: 150 -
High level of HBV DNA virus in the breast milk seems not to contraindicate breastfeeding
2213PDF: 831HTML: 957Untitled: 273 -
TUBERCULOSIS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES
3314PDF: 1257HTML: 8123 -
As a Rare Site of Invasive Fungal Infection, Chronic Granulomatous Aspergillus Synovitis: A Case Report
1735PDF: 631HTML: 1520Figure 1: MRI demonstrating Aspergillus synovitis: 189Figure 2:MRI demonstrating Aspergillus synovitis: 194 -
FROM LEGACY TO INNOVATION: PIDOTIMOD’S EXPANDING THERAPEUTIC HORIZON Pidotimod: Revisiting a Classic Immunomodulator
2598PDF: 960HTML: 577 -
JUSTIFICATION OF UNIVERSAL IRON SUPPLEMENTATION FOR INFANTS 6-12 MONTHS IN REGIONS WITH A HIGH PREVALENCE OF THALASSEMIA Iron Supplementation for Infants 6-12 months in Regions with a High Prevalence of Thalassemia
2281PDF: 617Suppl. Files: 285HTML: 176 -
SPLANCHNIC VEIN THROMBOSIS IN THE MEDITERRANEAN AREA IN CHILDREN
2203PDF: 925HTML: 1655 -
ADVANCES IN THE TREATMENT OF MALARIA
2872PDF: 1308HTML: 6001 -
HIV-ASSOCIATED VENOUS THROMBOEMBOLISM
3938PDF: 1491HTML: 8518 -
THE PERFORMANCE OF HOMA 2 COMPARED TO DYNAMIC MARKERS OF INSULIN SECRETION AND SENSITIVITY/RESISTANCE FOR PREDICTING DYSGLYCEMIA IN TRANSFUSION-DEPENDENT Β-THALASSEMIA: THE EXPERIENCE OF A SINGLE CENTRE HOMA 2 and DYNAMIC MARKERS OF INSULIN SECRETION FOR PREDICTING DYSGLYCEMIA in TDT
85PDF: 63HTML: 11 -
TUBERCULOSIS: EPIDEMIOLOGY AND CONTROL
7061PDF: 3983HTML: 24894 -
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1499PDF: 1084HTML: 223 -
Is laboratory monitoring useful in DOACs management?
851PDF: 815HTML: 111 -
COMPARISON OF IL-34, ELASTOGRAPHY, AND BIOPSY IN THE ASSESSMENT OF LIVER FIBROSIS IN CHRONIC HEPATITIS B Evaluating Non-Invasive and Invasive Methods in Liver Fibrosis
565PDF: 303Html: 25 -
Refractory Immune Thrombocytopenic Purpura and Cytomegalovirus Infection: A Call for a Change in the Current Guidelines
4273PDF: 1196HTML: 2170Figure 1: 170 -
Kikuchi-Fujimoto disease and hemophagocytic lymphohistiocytosis: a rare combination of two rare diseases
842PDF: 629Suppl. Files: 124HTML: 96 -
Improvement of liver involvement in familial Mediterranean fever after introduction of canakinumab: a case report Liver involvement in familial Mediterranean fever
1355PDF: 920HTML: 308 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4344PDF: 1385HTML: 2049 -
-
EFFECT OF FRESH VERSUS CRYOPRESERVED GRAFTS ON FEBRILE NEUTROPENIA AND INFECTIONS IN ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION: FACTORS DETERMINING MORTALITY. Fresh vs Frozen Grafts: Infection and Outcome
893PDF: 618HTML: 87 -
CAR-T CELL THERAPY FOR FOLLICULAR LYMPHOMAS CAR-T and Follicular Lymphoma
2343PDF: 1859HTML: 148 -
MYELODYSPLASTIC SYNDROMES AND IRON CHELATION THERAPY
3407PDF: 1298HTML: 1908Fig.1: 206Fig. 2: 216







